HTB

HIV 6 Glasgow 2002

6th International Congress on Drug Therapy in HIV Infection, 17-21 November 2002, Glasgow, UK

Combination of three generic drugs in one pill meets bioequivalence criteria when compared with the branded drugs: Triomune vs d4T/3TC/NVP

An overview of the conference

Pharmacokinetic evaluation of tenofovir and enteric-coated ddI

The advantages of fosamprenavir; comparing saquinavir/r to lopinavir/r; reducing viral load to <3 copies; AZT-d4T cross resistance; and rising HCV rates

Promising data regarding DermaVir for therapeutic vaccine

Enfuvirtide (T-20): predicting success and modelling survival benefits

Virologic failure among treatment-naive patients taking tenofovir DF or stavudine in combination with lamivudine and efavirenz

Comparison of the efficacy and safety of tenofovir vs. d4T when used in combination with 3TC and efavirenz in ARV-naive patients

Safety profile of tenofovir in treatment-experienced patients